| 12364664 |
Lyophilized compositions comprising arsenic |
Kumar Kurumaddali |
2025-07-22 |
| 11220524 |
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
Juan Luengo, Raul Andrew Leal, Hong Lin, Rupa Shetty |
2022-01-11 |
| 10653628 |
High surface-area lyophilized compositions comprising arsenic for oral administration in patients |
Kumar Kurumaddali |
2020-05-19 |
| 10272045 |
High surface-area lyophilized compositions comprising arsenic for oral administration in patients |
Kumar Kurumaddali |
2019-04-30 |
| 10111836 |
High surface-area lyophilized compositions comprising arsenic for oral administration in patients |
Kumar Kurumaddali |
2018-10-30 |
| 9345677 |
Compositions, methods and kits relating to HER-2 cleavage |
Steven M. Friedman, Peggy A. Scherle, Xiangdong Liu, Jordan S. Fridman |
2016-05-24 |
| 9206187 |
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase |
James D. Rodgers, Stacey Shepard, Jordan S. Fridman |
2015-12-08 |
| 8946245 |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
James D. Rodgers, Stacey Shepard, Jordan S. Fridman |
2015-02-03 |
| 8933086 |
Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors |
James D. Rodgers, Stacey Shepard, Jordan S. Fridman |
2015-01-13 |
| 8541425 |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
James D. Rodgers, Stacey Shepard, Jordan S. Fridman |
2013-09-24 |
| 8088737 |
Compositions, methods and kits relating to Her-2 cleavage |
Steven M. Friedman, Peggy A. Scherle, Xiangdong Liu, Timothy C. Burn, Reid Huber +3 more |
2012-01-03 |
| 7910108 |
Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases |
Steven M. Friedman, Robert C. Newton, Peggy A. Scherle |
2011-03-22 |